Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 8:13:321-337.
doi: 10.2147/CEG.S260600. eCollection 2020.

Quantitative Evaluation of D-Lactate Pathophysiology: New Insights into the Mechanisms Involved and the Many Areas in Need of Further Investigation

Affiliations
Review

Quantitative Evaluation of D-Lactate Pathophysiology: New Insights into the Mechanisms Involved and the Many Areas in Need of Further Investigation

Michael D Levitt et al. Clin Exp Gastroenterol. .

Abstract

In contrast to L-lactate, D-lactate is produced in minimal quantities by human cells, and the plasma D-lactate concentration normally is maintained at a concentration of only about 0.01 mM. However, in short bowel syndrome, colonic bacterial production of D-lactate may lead to plasma concentrations >3mM with accompanying acidosis and neurological symptoms - a syndrome known as D-lactic acidosis. Minor increases in plasma D-lactate have been observed in various gastrointestinal conditions such as ischemia, appendicitis and Crohn's disease, a finding touted to have diagnostic utility. The novel aspect of this review paper is the application of numerical values to the processes involved in D-lactate homeostasis that previously have been described only in qualitative terms. This approach provides a number of new insights into normal and disordered production, catabolism and excretion of D-lactate, and identifies multiple gaps in our understanding of D-lactate physiology that should be amenable to relatively simple investigative study.

Keywords: acidosis; delirium; short bowel syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Schematic representations of human and anaerobic bacterial metabolism of L- and D-lactate. Notes: 1, bacterial D-LDH catalyzes a reversible reaction between pyruvate and D-lactate (allowing for D-lactate production from pyruvate) while in humans this reaction irreversibly converts D-lactate to pyruvate; 2, the anaerobic bacteria cannot dispose of pyruvate via oxidative reactions, hence all pyruvate produced from glycolysis is converted to lactate or other organic acids such as acetate and butyrate.
Figure 2
Figure 2
Comparison of the plasma D-lactate experimental data (solid circles) of Connor et al following a 20 minute, 105 millimolar constant IV infusion versus the PBPK model prediction (line) assuming a whole body clearance of 607 mL/min and Km of 5 mM.
Figure 3
Figure 3
Plot of the PBPK model prediction of the plasma D-lactate concentration following 3 consecutive inputs of 500 millimoles of D-lactate with the time course described by eq. 3, each separated by 5 hours. It is assumed that the whole body clearance has the normal value of 607 mL/min. Top panel: input (see eq. 3): TT = 30 and TA = 40 minutes. Bottom panel: input TT = 30 and TA = 120 minutes.
Figure 4
Figure 4
Left panel: De Vrese and Barth experimental plasma D-lactate concentration following ingestion of 74 mmole of D-lactate as yoghurt (solid circles) versus the PBPK model prediction (solid line) for the normal whole body clearance of 607 mL/min. Right panel: The intestinal absorption rate used to generate the PBPK model plasma concentration (total absorption of 38.2 millimoles D-lactate, with absorption rate described by eq. 3: TT= 21.6 and TA = 116 minutes).
Figure 5
Figure 5
Schematic representation of the various processes that could influence the plasma D-lactate concentration. The direction of the solid arrows indicates whether an increase in the process potentially increases (up arrow) or decreases (down arrow) plasma D-lactate. For example, an increase in carbohydrate (CHO) ingestion would provide an increased substrate for intestinal bacteria and increase D-lactate production; while an increased CHO intestinal absorption rate would decrease the substrate for the intestinal bacteria and therefore, potentially, decrease plasma D-lactate.
Figure 6
Figure 6
Plot of the PBPK model prediction of the plasma D-lactate concentration following 3 consecutive inputs of 1000 millimoles of D-lactate with the time course described by eq. 3, each separated by 5 hours. It is assumed that the whole body clearance has the normal value of 607 mL/min. Top panel: input (see eq. 3): TT = 30 and TA = 40 minutes. Bottom panel: input TT = 30 and TA = 120 minutes.
Figure 7
Figure 7
Plot of the PBPK model prediction of the plasma D-lactate concentration following 3 consecutive inputs of 500 millimoles of D-lactate with the time course shown in Figure 3, each separated by 5 hours. It is assumed that the whole body clearance is 309 mL/min, half the normal value. Top panel: input (see eq. 3): TT = 30 and TA = 40 minutes. Bottom panel: input TT = 30 and TA = 120 minutes.

References

    1. Dunlop RH, Hammond PB. D-lactic acidosis of ruminants. Ann N Y Acad Sci. 1965;119(3):1109–1132. doi:10.1111/j.1749-6632.1965.tb47466.x - DOI - PubMed
    1. Lorenz I, Gentile A, Klee W. Investigations of D-lactate metabolism and the clinical signs of D-lactataemia in calves. Vet Rec. 2005;156(13):412–415. doi:10.1136/vr.156.13.412 - DOI - PubMed
    1. Oh MS, Phelps KR, Traube M, Barbosa-Saldivar JL, Boxhill C, Carroll HJ. D-lactic acidosis in a man with the short-bowel syndrome. N Engl J Med. 1979;301(5):249–252. doi:10.1056/NEJM197908023010505 - DOI - PubMed
    1. Bianchetti D, Amelio GS, Lava SAG, et al. D-lactic acidosis in humans: systematic literature review. Pediatr Nephrol. 2018;33(4):673–681. doi:10.1007/s00467-017-3844-8 - DOI - PubMed
    1. Rao SSC, Yu S, Tetangco EP, and Yan Y. Probiotics can cause D-lactic acidosis and brain fogginess: reply to Quigley et al. Clin Transl Gastroenterol. 2018;9:1–2. doi:10.1038/s41424-018-0077-5 - DOI - PMC - PubMed